Tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total community benefits in 2022. According to ...

Rather than using their federal 340B drug discount savings to lower costs for patients, many hospitals reinvest their profits into acquiring independent clinics.

The U.S. House Oversight Committee on Tuesday decided to subpoena AbbVie Inc to seek documents on the drugmaker's blockbuster treatments, Humira and Imbruvica, as part of its investigation into ...

In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...

A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the ...

Trump has called its initiative an “historic” step in drug pricing policy. But the lack of critical details makes it hard to ...

The Colorado Prescription Drug Affordability Review Board imposed a first-in-the-nation price cap on the drug Enbrel, starting in 2017.

Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain ...

The nation's top pharmaceutical trade group is taking a legal swing at Rhode Island's new drug-pricing law.

That’s why we need Senate Bill 41, authored by Sen. Scott Wiener, D-San Francisco, which will require a more fair and ...

The 340B Drug Pricing Program was created to benefit low-income and uninsured Americans. Over time, it has morphed into a federal subsidy for hospitals in affluent areas at the expense ...

The Kansas Legislature is currently considering a bill, SB 284, under seemingly noble pretense. Proponents of SB 284 argue ...